Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients-Reference-Cited by-同舟云学术

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Published:2009-07 Issue:1 Volume:92 Page:4-14
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Pignon Jean-Pierre,Maître Aurélie le,Maillard Emilie,Bourhis Jean

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference19 articles.

1. Ferlay F, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press; 2004.

2. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data;Pignon;Lancet,2000

3. A graphical method for exploring heterogeneity in meta-analysis: application to a meta-analysis of 65 trials;Baujat;Stat Med,2002

4. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update;Pignon;Int J Radiat Oncol Biol Phys,2007

5. A note on quantifying follow-up in studies of failure time;Schemper;Control Clin Trials,1996

Cited by 2457 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk and prognostic factors for lung metastases in oral squamous cell carcinoma: A population-based analysis of the SEER database;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-06

2. Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer;Clinical and Translational Radiation Oncology;2024-03

3. A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma;Artificial Cells, Nanomedicine, and Biotechnology;2024-02-05

4. DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma;Cellular Oncology;2024-02-05

5. Cancer of unknown primary—role of radiotherapy in multimodal treatment;Die Onkologie;2024-02-01